ResearcherUniversidad de AlcaláNo recent work listed

Ana Santos-Rebelo

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5030297162. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper

Papers 2

Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGFR-Overexpressing Pancreatic Cancer Cells. Co-author DOI 10.3390/cancers11111733 ↗
Development of Parvifloron D-loaded Smart Nanoparticles to Target Pancreatic Cancer. Co-author DOI 10.3390/pharmaceutics10040216 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Catarina Pinto Reis · 2 shared papers, 2018–2019 · strength 0.15
- Paper Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGF… DOI 10.3390/cancers11111733 ↗
- Paper Development of Parvifloron D-loaded Smart Nanoparticles to Target Pancreatic Cancer. DOI 10.3390/pharmaceutics10040216 ↗
Yahya Essop Choonara · 1 shared paper, 2019 · strength 0.08
- Paper Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGF… DOI 10.3390/cancers11111733 ↗
Manuel A. N. Coelho · 1 shared paper, 2018 · strength 0.07
- Paper Development of Parvifloron D-loaded Smart Nanoparticles to Target Pancreatic Cancer. DOI 10.3390/pharmaceutics10040216 ↗
Sílvia Castro Coelho · 1 shared paper, 2018 · strength 0.07
- Paper Development of Parvifloron D-loaded Smart Nanoparticles to Target Pancreatic Cancer. DOI 10.3390/pharmaceutics10040216 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.